Routine immunizations in adult renal transplant recipients

Transplantation

Volumn 63, Issue 6, 1997, Pages 839-845

  Huzly, D ^a,e   Neifer, S ^b   Reinke, P ^c   Schroder K ^d   Schonfeld C ^a   Hofmann, T ^c   Bienzle, U ^a  

^a Institute of Tropical Medicine   (Germany)

^b Institute of Microbiology and Hygiene   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Dialysezentrum   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DIPHTHERIA TETANUS VACCINE; POLIOMYELITIS VACCINE; PREDNISONE; TD RIX; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRELON C;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; COHORT STUDIES; DIPHTHERIA TOXOID; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLIOVIRUS VACCINE, INACTIVATED; REGRESSION ANALYSIS; TETANUS TOXOID; VACCINES, INACTIVATED;

EID: 0030998124     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703270-00008     Document Type: Article

References (32)

1. Belohradsky BH, Niβl L. Impfungen bei sekundären Immundefekten Indikationen, Impferfolge und Komplikationen. Ergebnisse der Inneren Medizin und Kinderheilkunde 1992; 60: 241.
2. Gershon AA. Immunizations for pediatric transplant patients. Kidney Int 1993; 44 (suppl 43): 87.
3. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet Dis Proc 1992; 22: 434.
4. Beyer WEP, Diepersloot RJA, Masurel N, Simoons ML, Weimar W. Double failure of influenza vaccination in a heart transplant patient. Transplantation 1987; 43: 319.
5. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Flik J. Failure of vaccination against hepatitis B with Gen-H-B-Vax-D in immunosuppressed heart transplant recipients. Clin Investig 1992; 70: 585.
6. Schröder JP, Kuhlmann WD. Tetanusimpfschutz und Vermeidung von Nebenreaktionen bei Auffrischimpfungen. Dtsch Med Wochenschr 1992; 117: 1903.
7. Miyamura K, Nishio S, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using Vero cells. J Biol Stan 1974; 2: 189.
8. Naumann P, Hagedorn H-J, Paatz R. Diphtherie-Immunität und ihre epidemiologische Bedeutung. Dtsch Med Wochenschr 1983; 108: 1090.
9. Anonymous. Expanded programme on immunization: rapid assessment of serological response to oral polio vaccine. Wkly Epidemiol Rec (WHO) 1990; 65: 34.5.
10. Gentili G, Pinit F, Collotti C. The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination. J Biol Stan 1985; 13: 53.
11. Sedgwick AK, Ballow M, Sparks K, Tilton RC. Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies. J Clin Microbiol 1983; 18: 104.
12. Girndt M, Pietsch M, Köhler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995; 26: 454.
13. Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995; 13: 443.
14. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994; 44: 446.
15. Anonymous. Tetanus: United States, 1987 and 1988. MMWR Morb Mortal Wkly Rep 1990; 39: 37.
16. Das Nationale Referenzzentrum für Diphtherie und Tetanus. Bundesgesundheitsblatt 1992; 11: 518.
17. Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis 1988; 20: 177.
18. Böttiger M, Pettersson G. Vaccine immunity to diphtheria: a 20 year follow-up study. J Infect Dis 1992; 24: 753.
19. Simonsen O, Badsberg JH, Kjeldsen K, Moller-Madsen B, Heron I. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Pathol Microbiol Immunol Scand 1986; 94: 77.
20. Björkholm B, Granström M, Wahl M, Hedström C-E, Hagberg L. Adverse reactions and immunogenicity in adults to regular and increased dosage of diphtheria vaccine. Eur J Clin Microbiol Infect Dis 1987; 6: 637.
21. Borkowsky W, Steele CJ, Grubman S, Moore T, LaRussa P, Krasinski K. Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr 1987; 110: 563.
22. Ridgway D, Wolff LJ. Active immunization of children with leukemia and other malignancies. Leuk Lymphoma 1993; 9: 177.
23. Stoloff I, Stout R, Myerson RM, Havens WP. Production of antibody in patients with uremia. N Engl J Med 1968; 259: 320.
24. Anonymous. Certification of poliomyelitis eradication: the Americas, 1994. MMWR Morb Mortal Wkly Rep 1994; 43: 720.
25. Faden H, Modlin JF, Thorns ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis 1990; 62: 1291.
26. Groom SN, Clewley J, Litton PA, Brown DW, Wyatt HV, Arya SC. Vaccine-associated poliomyelitis. Lancet 1994; 343: 609.
27. Guillot S, Otelea D, Delpeyroux F, Crainic R. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction. Vaccine 1994; 12: 503.
28. Moriniere BJ, van Loon FPL, Rhodes PH, et al. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet 1993; 341: 1545.
29. Kreuder J, Netz H. Besondere Aspekte der Infektionsprophylaxe und Impfungen nach Herztransplantation im Kindesalter. Z Tx Med 1992; 4: 65.
30. Green MS, Handsher R, Slepon R, Ashkenazi S, Mendelson E, Cohen D. Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine. Vaccine 1994; 12: 582.
31. Sixbey JW. Routine immunizations and the immunosuppressed child. Adv Pediatr Infect Dis 1987; 2: 79.
32. Pozzetto B, Genin C, Gaudin OG, et al. Live poliovirus vaccine in patients with chronic glomerulonephritis: effects on renal function and specific antibody response. Clin Nephrol 1987; 28: 194.